Advertisement

Topics

Cell Biosciences, Inc Company Profile

01:13 EDT 21st September 2017 | BioPortfolio

Cell Biosciences is commercializing instrumentation and reagent systems to bring analytics to biology. In the “post-genomic” age, new tools are in high demand to enable researchers to rapidly develop assays for specific proteins in complex biological samples. High priority needs include specific detection of protein variants, detection of low abundance proteins in small sample volumes and improved quantification and throughput. Cell Biosciences is focused on these priorities to deliver new technology that will be enabling in these areas. We anticipate launch of our first instrument platform in 2006.

Location

1050 Page Mill Road
Palo Alto
California
94303
United States of America

Contact

Phone: 650) 859-1485
Fax: (650) 845-3540
Email: info@cellbiosciences.com


News Articles [2794 Associated News Articles listed on BioPortfolio]

Pascal Biosciences acquires STC technology for B-cell precursor ALL treatment

Canadian drug discovery and development company Pascal Biosciences has executed an exclusive, worldwide licence option agreement with STC.UNM (STC) to purchase a therapeutic monoclonal antibody for B-...

Canopy Biosciences Enters Bioprocessing Market with Launch of Host Cell Protein Detection Kits

ST. LOUIS, July 13, 2017 /PRNewswire/ -- Canopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it will enter the bioprocessi...

Pascal Biosciences options leukemia antibody from STC.UNM

STC.UNM, the tech transfer unit of the University of New Mexico, has granted Pascal Biosciences Inc. a six-month option to license exclusive global rights to its technology surrounding a therapeutic m...

Ricerca Biosciences, LLC Renamed to Concord Biosciences, LLC After Sale of Chemical Development ...

According to Clifford W. Croleyof Main Market Partners and the CEO of Concord Biosciences, "We are very pleased to focus our complete energies Read more...

ACEA Biosciences Reports Positive Phase I Trial of BTK Inhibitor

ACEA Biosciences, a San Diego-Hangzhou company, has completed a successful Phase I trial of a novel irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor. ACEA makes and markets innovative tools...

Calithera Biosciences Announces FDA Fast Track Designation Granted to CB-839 for Treatment of Patients with Renal Cell Carcinoma

SOUTH SAN FRANCISCO, Calif., June 07, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therape...

Calithera begins Phase II trial of CB-839 to treat renal cell carcinoma

Pharmaceutical firm Calithera Biosciences has begun a Phase II clinical trial of CB-839 in combination with Afinitor (everolimus)‎ for the treatment of patients with renal cell carcinoma (RCC).

Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo ...

http://dailystocktracker.com/register/ Apricus Biosciences  On Tuesday, shares in San Diego, Californiaheadquartered Apricus Biosciences Inc. recorded a trading volume of 128,247 shares. The stoc...

Drugs and Medications [35 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [5724 Associated PubMed Articles listed on BioPortfolio]

Performance of FACSPresto Point-of-Care Instrument for CD4-T Cell Enumeration in Human Immunodeficiency Virus (HIV)-Infected Patients Attending Care and Treatment Clinics in Belgium and Tanzania.

CD4 T-cell counts are widely used to assess treatment eligibility and to follow-up HIV-infected patients. The World Health Organization prequalification of in vitro diagnostics program conducted a per...

Amnesia and criminal responsibility.

Introduction.

Back cover.

Contents list.

Clinical Trials [5196 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Cell-mediated immunity (CMI) and in particular T cells play a critical role in the rejection of transplanted organs. Thus, in transplant recipients a life-long and individualized immunosup...

A Study for Patients With Non-Hodgkin's Lymphomas

In this study, all patients will get investigational drug. There will be no comparator drug. This study will evaluate three tumor types: T-cell lymphoma, Indolent B-cell lymphoma, and A...

Companies [1222 Associated Companies listed on BioPortfolio]

InQ Biosciences Corporation

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company's InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to ce...

InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more...

Cell Biosciences, Inc

Cell Biosciences is commercializing instrumentation and reagent systems to bring analytics to biology. In the “post-genomic” age, new tools are in high demand to enable researchers to rapidly deve...

Cellex Biosciences Incorporated

Cellex Biosciences is dedicated to providing cell processing products and services to meet the needs of human health care and biotechnology markets worldwide with stirred tank cell culturing systems, ...

JRH Biosciences

JRH Biosciences, a CSL Company, is a provider of sera, cell culture media and specialty reagents to the global health care industry.

More Information about "Cell Biosciences, Inc" on BioPortfolio

We have published hundreds of Cell Biosciences, Inc news stories on BioPortfolio along with dozens of Cell Biosciences, Inc Clinical Trials and PubMed Articles about Cell Biosciences, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Biosciences, Inc Companies in our database. You can also find out about relevant Cell Biosciences, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record